BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 21404795)

  • 1. Parkinson's disease in the acute hospital.
    Jones SL; Hindle JV
    Clin Med (Lond); 2011 Feb; 11(1):84-8. PubMed ID: 21404795
    [No Abstract]   [Full Text] [Related]  

  • 2. Medication costs following subthalamic nucleus deep brain stimulation for Parkinson's disease.
    Toft M; Dietrichs E
    Mov Disord; 2014 Feb; 29(2):275-6. PubMed ID: 23696136
    [No Abstract]   [Full Text] [Related]  

  • 3. Deep-brain stimulation for Parkinson's disease.
    Okun MS
    N Engl J Med; 2012 Oct; 367(16):1529-38. PubMed ID: 23075179
    [No Abstract]   [Full Text] [Related]  

  • 4. Deep brain stimulation for advanced Parkinson's disease.
    Rodriguez-Oroz MC
    Lancet Neurol; 2010 Jun; 9(6):558-9. PubMed ID: 20434404
    [No Abstract]   [Full Text] [Related]  

  • 5. New research holds promise for Parkinson's treatment. New drugs and stem cell research offer encouraging glimpses of future therapies.
    Duke Med Health News; 2013 Dec; 19(12):1-2. PubMed ID: 24616930
    [No Abstract]   [Full Text] [Related]  

  • 6. Parkinson disease: deep brain stimulation versus best medical therapy for PD.
    Brodsky MA; Nutt JG
    Nat Rev Neurol; 2010 Oct; 6(10):530-2. PubMed ID: 20927052
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of subthalamic nucleus deep brain stimulation and Duodopa in the treatment of advanced Parkinson's disease.
    Merola A; Zibetti M; Angrisano S; Rizzi L; Lanotte M; Lopiano L
    Mov Disord; 2011 Mar; 26(4):664-70. PubMed ID: 21469197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variable frequency stimulation of subthalamic nucleus for freezing of gait in Parkinson's disease.
    Jia F; Guo Y; Wan S; Chen H; Hao H; Zhang J; Li L
    Parkinsonism Relat Disord; 2015 Dec; 21(12):1471-2. PubMed ID: 26467485
    [No Abstract]   [Full Text] [Related]  

  • 9. Functional peak dose dyskinesia in patients with Parkinson's disease.
    Baik JS; Lyoo CH; Lee JH; Chung SJ; Lee MS
    Parkinsonism Relat Disord; 2009 Jul; 15(6):475-6. PubMed ID: 19084463
    [No Abstract]   [Full Text] [Related]  

  • 10. Electroconvulsive therapy for depression in a Parkinson's disease patient with bilateral subthalamic nucleus deep brain stimulators.
    Chou KL; Hurtig HI; Jaggi JL; Baltuch GH; Pelchat RJ; Weintraub D
    Parkinsonism Relat Disord; 2005 Sep; 11(6):403-6. PubMed ID: 15994113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pallidal vs subthalamic deep brain stimulation for Parkinson disease: winner and loser or a sharing of honors?
    Minguez-Castellanos A; Escamilla-Sevilla F
    Arch Neurol; 2005 Oct; 62(10):1642-3; author reply 1643. PubMed ID: 16216956
    [No Abstract]   [Full Text] [Related]  

  • 12. An update on the diagnosis and treatment of Parkinson disease.
    Rizek P; Kumar N; Jog MS
    CMAJ; 2016 Nov; 188(16):1157-1165. PubMed ID: 27221269
    [No Abstract]   [Full Text] [Related]  

  • 13. Two cases of unexpected long-term improvement of Parkinson's disease after subthalamic nucleus deep brain stimulation removal.
    Wong SH; Eldridge PR; Duffy A; Fox SH; Varma TR; Fletcher NA
    Br J Neurosurg; 2011 Apr; 25(2):281-3. PubMed ID: 21344961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical Management of Parkinson's Disease after Initiation of Deep Brain Stimulation.
    Fasano A; Appel-Cresswell S; Jog M; Zurowkski M; Duff-Canning S; Cohn M; Picillo M; Honey CR; Panisset M; Munhoz RP
    Can J Neurol Sci; 2016 Sep; 43(5):626-34. PubMed ID: 27670207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parkinson's disease and deep brain stimulator placement.
    Deiner S; Hagen J
    Anesthesiol Clin; 2009 Sep; 27(3):391-415, table of contents. PubMed ID: 19825483
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Technology for deep brain stimulation at a gallop.
    Priori A
    Mov Disord; 2015 Aug; 30(9):1206-12. PubMed ID: 26011821
    [No Abstract]   [Full Text] [Related]  

  • 17. Outcomes from stimulation of the caudal zona incerta and pedunculopontine nucleus in patients with Parkinson's disease.
    Khan S; Mooney L; Plaha P; Javed S; White P; Whone AL; Gill SS
    Br J Neurosurg; 2011 Apr; 25(2):273-80. PubMed ID: 21344974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Available and emerging treatments for Parkinson's disease: a review.
    Hickey P; Stacy M
    Drug Des Devel Ther; 2011; 5():241-54. PubMed ID: 21607020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correspondence related to published material title "Deep brain stimulation may reduce the relative risk of clinically important worsening in early stage Parkinson's disease" by Hacker ML and colleague recently published electronically before print.
    Ostrem JL; Starr PA
    Parkinsonism Relat Disord; 2016 Apr; 25():112-3. PubMed ID: 26698683
    [No Abstract]   [Full Text] [Related]  

  • 20. Deep Brain Stimulation and Medication Management in Parkinson's Disease.
    Hutchinson K; Wick JY
    Consult Pharm; 2016 Feb; 31(2):73-84. PubMed ID: 26842685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.